https://orcid.org/0000-0001-8110-0641
Jean-Christophe received his PhD in Molecular Genetics from University Paris XI. During his PhD thesis at the Pasteur Institute, he was involved in the development of a yeast two-hybrid screening method allowing reproducible analysis of highly complex library by genetically saturated screening. In 1998, Dr. Rain was one of the founders of Hybrigenics where he took over the Head of Small Genome program and generated a genome-wide protein interaction map of Helicobacter pylori. From 2000 to 2005, he was responsible for internal and collaborative target identification and drug discovery programs in oncology and virology. Since 2010, in close collaboration with F. Perez and S. Moutel (Curie Institute, Paris), he develops new tools and libraries for antibody fragment selection in vitro and in yeast. From 2006 to 2019 Jean-Christophe was CSO of Hybrigenics Services SAS, he is leading the Yeast Two-Hybrid, Chemical proteomic and VHH selection platform. He was appointed as CEO in December 2019.
Hybrigenics Services SAS has leading expertise in protein-protein interactions based on yeast two-hybrid and phage display approaches. The company also specializes in development and screening of antibody fragments, VHH, with access to large synthetic Llama minibody libraries for customized Nanobody® selection, validation and affinity maturation. Hybrigenics has been Partner on several European grants